Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Urinary Bladder Neoplasms 12Neoplasms 10Carcinoma, Renal Cell 9Ovarian Neoplasms 7Carcinoma, Transitional Cell 7Neoplasm Metastasis 6Pancreatic Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Merkel Cell 4Triple Negative Breast Neoplasms 3Recurrence 3Lymphoma 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Melanoma 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Kidney Diseases 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Urothelial Cancer 1Urologic Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1

Interventions

sacituzumab govitecan 1bintrafusp alfa protein, human 1avelumab 1Tomography, X-Ray Computed 1Nivolumab 1Ipilimumab 1Electrocardiography 1Echocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Metastatic Solid Tumors × avelumab × Clear all
NCT03523390 2024-02-23

Phase I/Ib Multiple Ascending Dose Study in China

Merck KGaA, Darmstadt, Germany

Phase 1 Completed
24 enrolled 24 charts
Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡